Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Resource updated 05/15/2024
Tool for service and program monitoring.
Resource updated 09/19/2023
This resource is a tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
Pre-application webinars for Notice of Funding Opportunity (NOFO) announcements from HRSA's HIV/AIDS Bureau for the Ryan White HIV/AIDS Program (RWHAP).
Resource updated 03/07/2024
Tool for assessing your organization’s strengths and gaps in areas that (1) are important to insurers and (2) support maximizing revenue from contracting activities.
Resource updated 10/05/2023
Insights to ADAP procedures for seeking rebates when a prescription is filled by another 340B entity pharmacy.
Resource updated 03/05/2024
Resource from the RWHAP Best Practices Compilation updated on 07/24/2024